Denali Therapeutics Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

FY: Dec 31 2021

Q: Sep 30 2021

Results of Operations and Financial Condition

Completion of Acquisition or Disposition of Assets

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

Regulation FD Disclosure

Results of Operations and Financial Condition

Termination of a Material Definitive Agreement

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Automatic Shelf Registration

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Automatic Shelf Registration

06b

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Automatic Shelf Registration

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Automatic Shelf Registration

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Chin Peter Scott

Chin Peter Scott

Thornberry Nancy

Schuth Alexander O.

Thornberry Nancy

Schuth Alexander O.

Watts Ryan J.

Schuth Alexander O.

Schuth Alexander O.

BAILLIE GIFFORD & CO

T. Rowe Price Investment Management, Inc.

Krognes Steve E.

Van Hauwermeiren Timothy

BAKER JULIAN; BAKER FELIX; BAKER BROS. ADVISORS LP; Baker Brothers Life Sciences LP; 667, L.P.; Baker Bros. Advisors (GP) LLC

Thornberry Nancy

Cook Jennifer E.

Schenkein David P

FLATLEY JAY T

Klein Peter S

T. Rowe Price Investment Management, Inc.

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

No description available

No description available

No description available

No description available

No description available

Correspondence with the SEC

Correspondence with the SEC

No description available

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC